EMPLOYMENT AGREEMENTEmployment Agreement • March 17th, 2014 • Galena Biopharma, Inc. • Pharmaceutical preparations • Oregon
This Employment Agreement (this “Agreement”) is made and entered into as of November, 7, 2013 (the “Effective Date”) by and between Galena Biopharma, Inc., a Delaware corporation (the “Company”, or “Employer”), and Brian L. Hamilton, M.D., Ph.D. an individual and resident of the State of (Massachusetts).
LICENSE AND DEVELOPMENT AGREEMENTLicense and Development Agreement • March 17th, 2014 • Galena Biopharma, Inc. • Pharmaceutical preparations • Delaware
This License and Development Agreement (as it may be amended as provided herein, this “Agreement”) is entered into as of January 13, 2014 (the “Effective Date”) by and among Galena Biopharma, Inc., a corporation organized under the laws of the State of Delaware, U.S.A. (“Galena”), and Apthera, Inc., a Delaware corporation and wholly owned subsidiary of Galena (“Apthera” and, together with Galena, “Licensor”), each having its principal place of business at 4640 S.W. Macadam Avenue, Suite 270, Portland, Oregon, U.S.A. 97239, on the one hand, and Dr. Reddy’s Laboratories Limited, a company organized under the laws of India, having its principal place of business at Door No. 8-2-337, Road No. 3, Banjara Hills, Hyderbad 50034, Andra Pradesh, India (“Licensee”), on the other hand. Licensor and Licensee are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • March 17th, 2014 • Galena Biopharma, Inc. • Pharmaceutical preparations • New York
THIS EXCUSIVE LICENSE AGREEMENT (the “Agreement”) is entered into as of December 20, 2013 (the “Effective Date”) by and between Mills Pharmaceuticals, LLC., a Delaware limited liability company having an address at 557 Seventh Street, Brooklyn, NY 11215 (“MPI”), and BioVascular, Inc., a Delaware corporation having an address at P.O. Box #2343, Rancho Santa Fe, California 92067 (“BVI”). BVI and MPI may be referred to herein individually as a “Party” or collectively, as the “Parties.”
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 17th, 2014 • Galena Biopharma, Inc. • Pharmaceutical preparations • Delaware
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), is made and entered into as of January 12, 2014, by and among the members of Mills Pharmaceuticals, LLC, a Delaware limited liability company (the “Company”), as identified on the signature pages attached to this Agreement (each such party, an “Owner” and collectively, the “Owners”), and Galena Biopharma, Inc., a Delaware corporation (“Buyer”). The Owners and Buyer may be referred to individually as a “Party” and collectively as the “Parties. Capitalized terms used but not defined in this Agreement shall have the meanings provided in that certain Unit Purchase Agreement (the “Purchase Agreement”) by and among the Parties hereto and the Company and dated as of the date hereof.
UNIT PURCHASE AGREEMENTUnit Purchase Agreement • March 17th, 2014 • Galena Biopharma, Inc. • Pharmaceutical preparations • Delaware
THIS UNIT PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of January 12, 2014, by and among Mills Pharmaceuticals, LLC, a Delaware limited liability company (the “Company”), the members of the Company as identified on the signature pages attached to this Agreement (each such party, an “Owner” and collectively, the “Owners”), Galena Biopharma, Inc., a Delaware corporation (“Buyer”), and Aceras Partners, LLC, a Delaware limited liability company (the “Representative”), solely in its capacity as Representative. The Company, the Owners, Buyer and the Representative may be referred to individually as a “Party” and collectively as the “Parties.” Capitalized terms used but not defined herein shall have the meanings given in Article VIII hereof.
